{"count":220751,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1261","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1259","results":[{"created":"2021-07-25T17:58:02.185364+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8506","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cybb has been classified as Green List (High Evidence).","entity_name":"CYBB","entity_type":"gene"},{"created":"2021-07-25T17:57:52.920156+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8506","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CYBB were changed from  to Chronic granulomatous disease, X-linked, MIM# 306400","entity_name":"CYBB","entity_type":"gene"},{"created":"2021-07-25T17:57:32.399018+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8505","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CYBB were set to ","entity_name":"CYBB","entity_type":"gene"},{"created":"2021-07-25T17:57:13.059805+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8504","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CYBB was changed from Unknown to X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"CYBB","entity_type":"gene"},{"created":"2021-07-25T17:56:53.793653+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8503","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CYBB: Rating: GREEN; Mode of pathogenicity: None; Publications: 2556453, 1710153, 9585602; Phenotypes: Chronic granulomatous disease, X-linked, MIM# 306400; Mode of inheritance: X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"CYBB","entity_type":"gene"},{"created":"2021-07-25T17:56:00.856797+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.84","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CYBB as ready","entity_name":"CYBB","entity_type":"gene"},{"created":"2021-07-25T17:56:00.846552+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.84","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cybb has been classified as Green List (High Evidence).","entity_name":"CYBB","entity_type":"gene"},{"created":"2021-07-25T17:55:58.571384+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.84","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CYBB were changed from  to Chronic granulomatous disease, X-linked, MIM# 306400","entity_name":"CYBB","entity_type":"gene"},{"created":"2021-07-25T17:55:33.771201+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.83","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CYBB were set to ","entity_name":"CYBB","entity_type":"gene"},{"created":"2021-07-25T17:55:00.914435+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.82","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CYBB was changed from Unknown to X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"CYBB","entity_type":"gene"},{"created":"2021-07-25T17:42:12.498644+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.81","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CTSC as ready","entity_name":"CTSC","entity_type":"gene"},{"created":"2021-07-25T17:42:12.489473+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.81","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ctsc has been classified as Green List (High Evidence).","entity_name":"CTSC","entity_type":"gene"},{"created":"2021-07-25T17:42:10.207630+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.81","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CTSC were changed from  to Papillon-Lefevre syndrome, MIM# 245000","entity_name":"CTSC","entity_type":"gene"},{"created":"2021-07-25T17:41:42.467878+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.80","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CTSC were set to ","entity_name":"CTSC","entity_type":"gene"},{"created":"2021-07-25T17:41:08.736947+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.79","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CTSC was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CTSC","entity_type":"gene"},{"created":"2021-07-25T17:40:41.110462+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.78","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CTSC: Rating: GREEN; Mode of pathogenicity: None; Publications: 25244098; Phenotypes: Papillon-Lefevre syndrome, MIM# 245000; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CTSC","entity_type":"gene"},{"created":"2021-07-25T17:35:41.807723+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"1.4","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CSF3R were changed from Neutropenia, severe congenital, 7, autosomal recessive, MIM#\t617014 to Neutropaenia, severe congenital, 7, autosomal recessive, MIM#\t617014","entity_name":"CSF3R","entity_type":"gene"},{"created":"2021-07-25T17:35:26.220026+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8503","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CSF3R as ready","entity_name":"CSF3R","entity_type":"gene"},{"created":"2021-07-25T17:35:26.209286+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8503","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: csf3r has been classified as Green List (High Evidence).","entity_name":"CSF3R","entity_type":"gene"},{"created":"2021-07-25T17:35:04.476160+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8503","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CSF3R were changed from Neutropenia, severe congenital, 7, autosomal recessive, MIM# 617014 to Neutropaenia, severe congenital, 7, autosomal recessive, MIM# 617014","entity_name":"CSF3R","entity_type":"gene"},{"created":"2021-07-25T17:34:41.031719+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"1.3","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CSF3R were set to 24753537; 26324699","entity_name":"CSF3R","entity_type":"gene"},{"created":"2021-07-25T17:34:33.879816+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8502","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CSF3R were changed from  to Neutropenia, severe congenital, 7, autosomal recessive, MIM# 617014","entity_name":"CSF3R","entity_type":"gene"},{"created":"2021-07-25T17:34:12.018415+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"1.2","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: CSF3R: Changed publications: 24753537, 26324699, 33511998, 32966608; Changed phenotypes: Neutropenia, severe congenital, 7, autosomal recessive, MIM# 617014","entity_name":"CSF3R","entity_type":"gene"},{"created":"2021-07-25T17:34:09.744201+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8501","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CSF3R were set to ","entity_name":"CSF3R","entity_type":"gene"},{"created":"2021-07-25T17:33:54.130232+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8500","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CSF3R was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CSF3R","entity_type":"gene"},{"created":"2021-07-25T17:33:36.840738+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8499","user_name":"Zornitza Stark","item_type":"entity","text":"changed review comment from: More than 5 unrelated families reported.; to: More than 5 unrelated families reported. Some reports of progression to myelodysplasia.","entity_name":"CSF3R","entity_type":"gene"},{"created":"2021-07-25T17:33:19.237855+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8499","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CSF3R: Rating: GREEN; Mode of pathogenicity: None; Publications: 24753537, 26324699, 33511998, 32966608; Phenotypes: Neutropenia, severe congenital, 7, autosomal recessive, MIM# 617014; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CSF3R","entity_type":"gene"},{"created":"2021-07-25T17:33:15.698712+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"1.2","user_name":"Zornitza Stark","item_type":"entity","text":"changed review comment from: Three unrelated families reported. \nSources: Expert list; to: At least 5 unrelated families reported. Some reports of progression to myelodysplasia.\r\nSources: Expert list","entity_name":"CSF3R","entity_type":"gene"},{"created":"2021-07-25T17:31:31.230680+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.78","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CSF3R as ready","entity_name":"CSF3R","entity_type":"gene"},{"created":"2021-07-25T17:31:31.220421+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.78","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: csf3r has been classified as Green List (High Evidence).","entity_name":"CSF3R","entity_type":"gene"},{"created":"2021-07-25T17:31:28.715534+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.78","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CSF3R were changed from  to Neutropaenia, severe congenital, 7, autosomal recessive, MIM# 617014","entity_name":"CSF3R","entity_type":"gene"},{"created":"2021-07-25T17:31:09.400186+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.77","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CSF3R were set to ","entity_name":"CSF3R","entity_type":"gene"},{"created":"2021-07-25T17:30:41.250994+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.76","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CSF3R was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CSF3R","entity_type":"gene"},{"created":"2021-07-25T17:30:17.104740+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.75","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CSF3R: Rating: GREEN; Mode of pathogenicity: None; Publications: 24753537, 26324699, 33511998, 32966608; Phenotypes: Neutropenia, severe congenital, 7, autosomal recessive, MIM# 617014; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CSF3R","entity_type":"gene"},{"created":"2021-07-25T17:26:51.867746+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8499","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NUAK2 were changed from Anencephaly to Anencephaly 2, MIM# 619452","entity_name":"NUAK2","entity_type":"gene"},{"created":"2021-07-25T17:26:25.569262+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8498","user_name":"Zornitza Stark","item_type":"entity","text":"Deleted their comment","entity_name":"NUAK2","entity_type":"gene"},{"created":"2021-07-25T17:26:17.885503+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8498","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: NUAK2: Changed phenotypes: Anencephaly 2, MIM# 619452","entity_name":"NUAK2","entity_type":"gene"},{"created":"2021-07-25T17:25:46.740970+10:00","panel_name":"Susceptibility to Viral Infections","panel_id":237,"panel_version":"0.77","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: DBR1 were changed from Viral infections of the brainstem to {Encephalitis, acute, infection (viral)-induced, susceptibility to, 11}, MIM# 619441; Viral infections of the brainstem","entity_name":"DBR1","entity_type":"gene"},{"created":"2021-07-25T17:25:17.805040+10:00","panel_name":"Susceptibility to Viral Infections","panel_id":237,"panel_version":"0.76","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: DBR1: Changed phenotypes: {Encephalitis, acute, infection (viral)-induced, susceptibility to, 11}, MIM# 619441, Viral infections of the brainstem","entity_name":"DBR1","entity_type":"gene"},{"created":"2021-07-25T17:24:59.454412+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8498","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: DBR1 were changed from Viral infections of the brainstem to {Encephalitis, acute, infection (viral)-induced, susceptibility to, 11}, MIM# 619441; Viral infections of the brainstem","entity_name":"DBR1","entity_type":"gene"},{"created":"2021-07-25T17:24:38.710442+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8497","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: DBR1: Changed phenotypes: {Encephalitis, acute, infection (viral)-induced, susceptibility to, 11}, MIM# 619441, Viral infections of the brainstem","entity_name":"DBR1","entity_type":"gene"},{"created":"2021-07-25T17:23:46.541746+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4001","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: DPYSL5 were changed from Neurodevelopmental disorder with corpus callosum agenesis and cerebellar abnormalities to Ritscher-Schinzel syndrome 4, MIM# 619435; Neurodevelopmental disorder with corpus callosum agenesis and cerebellar abnormalities","entity_name":"DPYSL5","entity_type":"gene"},{"created":"2021-07-25T17:23:16.200044+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4000","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: DPYSL5: Changed phenotypes: Ritscher-Schinzel syndrome 4, MIM# 619435, Neurodevelopmental disorder with corpus callosum agenesis and cerebellar abnormalities","entity_name":"DPYSL5","entity_type":"gene"},{"created":"2021-07-25T17:22:54.743109+10:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.307","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: DPYSL5 were changed from Neurodevelopmental disorder with corpus callosum agenesis and cerebellar abnormalities to Ritscher-Schinzel syndrome 4, MIM# 619435; Neurodevelopmental disorder with corpus callosum agenesis and cerebellar abnormalities","entity_name":"DPYSL5","entity_type":"gene"},{"created":"2021-07-25T17:22:22.136026+10:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.306","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: DPYSL5: Changed phenotypes: Ritscher-Schinzel syndrome 4, MIM# 619435, Neurodevelopmental disorder with corpus callosum agenesis and cerebellar abnormalities","entity_name":"DPYSL5","entity_type":"gene"},{"created":"2021-07-25T17:22:03.997700+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8497","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: DPYSL5 were changed from Neurodevelopmental disorder with corpus callosum agenesis and cerebellar abnormalities to Ritscher-Schinzel syndrome 4, MIM# 619435; Neurodevelopmental disorder with corpus callosum agenesis and cerebellar abnormalities","entity_name":"DPYSL5","entity_type":"gene"},{"created":"2021-07-25T17:21:41.361972+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8496","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: DPYSL5: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Ritscher-Schinzel syndrome 4, MIM# 619435; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"DPYSL5","entity_type":"gene"},{"created":"2021-07-25T14:18:13.562101+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"1.35","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: RRP7A were changed from Microcephaly to Microcephaly 28, primary, autosomal recessive MIM#619453","entity_name":"RRP7A","entity_type":"gene"},{"created":"2021-07-25T14:17:41.815751+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"1.34","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: RRP7A: Changed phenotypes: Microcephaly 28, primary, autosomal recessive MIM#619453","entity_name":"RRP7A","entity_type":"gene"},{"created":"2021-07-25T14:17:25.212379+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8496","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: RRP7A were changed from Microcephaly to Microcephaly 28, primary, autosomal recessive MIM#619453","entity_name":"RRP7A","entity_type":"gene"},{"created":"2021-07-25T14:16:53.180675+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8495","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: RRP7A: Changed phenotypes: Microcephaly 28, primary, autosomal recessive MIM#619453","entity_name":"RRP7A","entity_type":"gene"},{"created":"2021-07-24T18:35:26.027748+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.75","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CYBA as ready","entity_name":"CYBA","entity_type":"gene"},{"created":"2021-07-24T18:35:26.017371+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.75","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cyba has been classified as Green List (High Evidence).","entity_name":"CYBA","entity_type":"gene"},{"created":"2021-07-24T18:35:22.014100+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.75","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CYBA were changed from  to Chronic granulomatous disease 4, autosomal recessive, MIM# 233690; MONDO:0009308","entity_name":"CYBA","entity_type":"gene"},{"created":"2021-07-24T18:35:03.725099+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.74","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CYBA were set to ","entity_name":"CYBA","entity_type":"gene"},{"created":"2021-07-24T18:34:35.406304+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.73","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CYBA was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CYBA","entity_type":"gene"},{"created":"2021-07-24T18:33:44.192691+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8495","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CEBPE as ready","entity_name":"CEBPE","entity_type":"gene"},{"created":"2021-07-24T18:33:44.182020+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8495","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cebpe has been classified as Green List (High Evidence).","entity_name":"CEBPE","entity_type":"gene"},{"created":"2021-07-24T18:33:37.326569+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.72","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CEBPE as ready","entity_name":"CEBPE","entity_type":"gene"},{"created":"2021-07-24T18:33:37.310906+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.72","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cebpe has been classified as Green List (High Evidence).","entity_name":"CEBPE","entity_type":"gene"},{"created":"2021-07-24T18:33:29.463090+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.72","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CEBPE were changed from Specific granule deficiency, MIM# 245480 to Specific granule deficiency, MIM# 245480","entity_name":"CEBPE","entity_type":"gene"},{"created":"2021-07-24T18:33:13.979698+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.71","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CEBPE were changed from Specific granule deficiency, MIM# 245480 to Specific granule deficiency, MIM# 245480","entity_name":"CEBPE","entity_type":"gene"},{"created":"2021-07-24T18:33:12.053550+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8495","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CEBPE were changed from  to Specific granule deficiency, MIM# 245480","entity_name":"CEBPE","entity_type":"gene"},{"created":"2021-07-24T18:32:58.714076+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.71","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CEBPE were changed from  to Specific granule deficiency, MIM# 245480","entity_name":"CEBPE","entity_type":"gene"},{"created":"2021-07-24T18:32:46.502468+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8494","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CEBPE were set to ","entity_name":"CEBPE","entity_type":"gene"},{"created":"2021-07-24T18:32:14.238026+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8493","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CEBPE was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CEBPE","entity_type":"gene"},{"created":"2021-07-24T18:31:57.523555+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.70","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CEBPE were set to ","entity_name":"CEBPE","entity_type":"gene"},{"created":"2021-07-24T18:31:50.333779+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8492","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CEBPE: Rating: GREEN; Mode of pathogenicity: None; Publications: 10359588, 11313242, 31256937, 29651288; Phenotypes: Specific granule deficiency, MIM# 245480; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CEBPE","entity_type":"gene"},{"created":"2021-07-24T18:31:09.464534+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.69","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CEBPE was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CEBPE","entity_type":"gene"},{"created":"2021-07-24T18:30:37.173536+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.68","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CEBPE: Rating: GREEN; Mode of pathogenicity: None; Publications: 10359588, 11313242, 31256937, 29651288; Phenotypes: Specific granule deficiency, MIM# 245480; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CEBPE","entity_type":"gene"},{"created":"2021-07-24T17:05:41.192781+10:00","panel_name":"Chronic granulomatous disease","panel_id":3159,"panel_version":"1.0","user_name":"Zornitza Stark","item_type":"panel","text":"promoted panel to version 1.0","entity_name":null,"entity_type":null},{"created":"2021-07-24T17:04:16.155878+10:00","panel_name":"Chronic granulomatous disease","panel_id":3159,"panel_version":"0.18","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: G6PD as ready","entity_name":"G6PD","entity_type":"gene"},{"created":"2021-07-24T17:04:16.137640+10:00","panel_name":"Chronic granulomatous disease","panel_id":3159,"panel_version":"0.18","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: g6pd has been classified as Green List (High Evidence).","entity_name":"G6PD","entity_type":"gene"},{"created":"2021-07-24T17:04:11.585139+10:00","panel_name":"Chronic granulomatous disease","panel_id":3159,"panel_version":"0.18","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: G6PD were set to ","entity_name":"G6PD","entity_type":"gene"},{"created":"2021-07-24T17:03:53.327315+10:00","panel_name":"Chronic granulomatous disease","panel_id":3159,"panel_version":"0.17","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: G6PD: Rating: GREEN; Mode of pathogenicity: None; Publications: 34175765, 27458052; Phenotypes: Haemolytic anemia, G6PD deficient (favism), MIM# 300908; Mode of inheritance: X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"G6PD","entity_type":"gene"},{"created":"2021-07-24T17:01:50.915296+10:00","panel_name":"Chronic granulomatous disease","panel_id":3159,"panel_version":"0.17","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: C17orf62 as ready","entity_name":"C17orf62","entity_type":"gene"},{"created":"2021-07-24T17:01:50.896835+10:00","panel_name":"Chronic granulomatous disease","panel_id":3159,"panel_version":"0.17","user_name":"Zornitza Stark","item_type":"entity","text":"Added comment: Comment when marking as ready: HGNC approved name: CYBC1","entity_name":"C17orf62","entity_type":"gene"},{"created":"2021-07-24T17:01:50.852266+10:00","panel_name":"Chronic granulomatous disease","panel_id":3159,"panel_version":"0.17","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: c17orf62 has been classified as Green List (High Evidence).","entity_name":"C17orf62","entity_type":"gene"},{"created":"2021-07-24T17:01:33.442360+10:00","panel_name":"Chronic granulomatous disease","panel_id":3159,"panel_version":"0.17","user_name":"Zornitza Stark","item_type":"entity","text":"Tag new gene name tag was added to gene: C17orf62.","entity_name":"C17orf62","entity_type":"gene"},{"created":"2021-07-24T17:00:44.441021+10:00","panel_name":"Chronic granulomatous disease","panel_id":3159,"panel_version":"0.17","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NCF2 as ready","entity_name":"NCF2","entity_type":"gene"},{"created":"2021-07-24T17:00:44.431099+10:00","panel_name":"Chronic granulomatous disease","panel_id":3159,"panel_version":"0.17","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ncf2 has been classified as Green List (High Evidence).","entity_name":"NCF2","entity_type":"gene"},{"created":"2021-07-24T17:00:36.316441+10:00","panel_name":"Chronic granulomatous disease","panel_id":3159,"panel_version":"0.17","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: NCF2 were set to ","entity_name":"NCF2","entity_type":"gene"},{"created":"2021-07-24T17:00:19.955076+10:00","panel_name":"Chronic granulomatous disease","panel_id":3159,"panel_version":"0.16","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NCF2: Rating: GREEN; Mode of pathogenicity: None; Publications: 7795241, 10498624; Phenotypes: Chronic granulomatous disease 2, autosomal recessive, MIM# 233710; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NCF2","entity_type":"gene"},{"created":"2021-07-24T16:59:06.040567+10:00","panel_name":"Chronic granulomatous disease","panel_id":3159,"panel_version":"0.16","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CYBB as ready","entity_name":"CYBB","entity_type":"gene"},{"created":"2021-07-24T16:59:06.031097+10:00","panel_name":"Chronic granulomatous disease","panel_id":3159,"panel_version":"0.16","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cybb has been classified as Green List (High Evidence).","entity_name":"CYBB","entity_type":"gene"},{"created":"2021-07-24T16:59:01.885240+10:00","panel_name":"Chronic granulomatous disease","panel_id":3159,"panel_version":"0.16","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CYBB were set to ","entity_name":"CYBB","entity_type":"gene"},{"created":"2021-07-24T16:58:49.118154+10:00","panel_name":"Chronic granulomatous disease","panel_id":3159,"panel_version":"0.15","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CYBB: Rating: GREEN; Mode of pathogenicity: None; Publications: 2556453, 1710153, 9585602; Phenotypes: Chronic granulomatous disease, X-linked, MIM# 306400; Mode of inheritance: X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"CYBB","entity_type":"gene"},{"created":"2021-07-24T10:38:20.225285+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.102","user_name":"Sarah Righetti","item_type":"entity","text":"reviewed gene: GK: Rating: RED; Mode of pathogenicity: None; Publications: 8651297, 9719371; Phenotypes: Glycerol kinase deficiency, MIM# 307030; Mode of inheritance: None","entity_name":"GK","entity_type":"gene"},{"created":"2021-07-24T10:26:06.670541+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.102","user_name":"Sarah Righetti","item_type":"entity","text":"reviewed gene: SAMD9: Rating: AMBER; Mode of pathogenicity: None; Publications: 16960814, 18094730; Phenotypes: Tumoral calcinosis, familial, normophosphatemic, MIM# 610455; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"SAMD9","entity_type":"gene"},{"created":"2021-07-24T10:15:08.386003+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.102","user_name":"Sarah Righetti","item_type":"entity","text":"reviewed gene: FTCD: Rating: RED; Mode of pathogenicity: None; Publications: PMID: 5956503, 5897668, 4413489, 29178637; Phenotypes: Glutamate formiminotransferase deficiency MIM#229100; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"FTCD","entity_type":"gene"},{"created":"2021-07-23T13:38:45.452207+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8492","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NCF1 as ready","entity_name":"NCF1","entity_type":"gene"},{"created":"2021-07-23T13:38:45.433847+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8492","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ncf1 has been classified as Green List (High Evidence).","entity_name":"NCF1","entity_type":"gene"},{"created":"2021-07-23T13:38:29.775161+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8492","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NCF1 were changed from  to Chronic granulomatous disease 1, autosomal recessive, MIM# 233700","entity_name":"NCF1","entity_type":"gene"},{"created":"2021-07-23T13:38:00.982979+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8491","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: NCF1 were set to ","entity_name":"NCF1","entity_type":"gene"},{"created":"2021-07-23T13:37:42.544334+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8490","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: NCF1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"NCF1","entity_type":"gene"},{"created":"2021-07-23T13:37:25.213077+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8489","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NCF1: Rating: GREEN; Mode of pathogenicity: None; Publications: 2011585, 11133775, 10706888, 16972229, 16972229; Phenotypes: Chronic granulomatous disease 1, autosomal recessive, MIM# 233700; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NCF1","entity_type":"gene"},{"created":"2021-07-23T13:36:34.091091+10:00","panel_name":"Chronic granulomatous disease","panel_id":3159,"panel_version":"0.15","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NCF1 as ready","entity_name":"NCF1","entity_type":"gene"},{"created":"2021-07-23T13:36:34.076193+10:00","panel_name":"Chronic granulomatous disease","panel_id":3159,"panel_version":"0.15","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ncf1 has been classified as Green List (High Evidence).","entity_name":"NCF1","entity_type":"gene"},{"created":"2021-07-23T13:36:31.727703+10:00","panel_name":"Chronic granulomatous disease","panel_id":3159,"panel_version":"0.15","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NCF1 were changed from Chronic granulomatous disease due to deficiency of NCF-1 MIM#233700 to Chronic granulomatous disease 1, autosomal recessive, MIM# 233700","entity_name":"NCF1","entity_type":"gene"},{"created":"2021-07-23T13:36:19.035882+10:00","panel_name":"Chronic granulomatous disease","panel_id":3159,"panel_version":"0.14","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: NCF1 were set to ","entity_name":"NCF1","entity_type":"gene"}]}